Local company, Bedfont® Scientific, urges people to quit smoking with the Smokerlyzer® after latest figures from Action on Smoking and Health (ASH) find smoking still causes the majority of lung cancer deaths in the UK.
Lung Cancer Awareness month approaches again in November 2016, in the hope to make people aware of the facts and figures that can save people’s lives. Bedfont® Scientific, based in Harrietsham, Kent, manufacturer of the Smokerlyzer®, a breath carbon monoxide (CO) monitor used to help people quit smoking, is encouraging people to quit the habit which contributes to 86% of lung cancer deaths in men and 72% in women, according to latest ASH statistics.
A staggering 81% of patients diagnosed with advanced lung cancer die within a year and smoking is the single biggest preventable risk factor of lung cancer.
A leading manufacturer of exhaled breath and gas monitoring instruments, who in 2016 are celebrating two important anniversaries – 40 years in business and 30 years of one of their most successful exports – the Smokerlyzer®, Bedfont® Scientific are revered as pioneers in the medical gas analysis market.
Jason Smith, Managing Director at Bedfont® Scientific, comments:
The Smokerlyzer® uses breath analysis to detect the harmful amount of carbon monoxide (CO) in your lungs, and therefore your blood, that is inhaled from smoking. Smoking builds high levels of CO in the blood, which can lead to heart disease, circulation problems and high blood pressure. For smoking cessation clinics, it is a way to establish a smoker’s status whilst acting as a motivational visual aid to encourage them to quit and to measure their progress whilst doing so, helping to prevent cancer and other smoking related diseases.